| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria | 40 | 2022 | 643 | 4.360 |
Why?
|
| Retinitis Pigmentosa | 3 | 2021 | 17 | 1.480 |
Why?
|
| Small Molecule Libraries | 3 | 2021 | 53 | 1.350 |
Why?
|
| Protective Agents | 2 | 2021 | 36 | 1.270 |
Why?
|
| Energy Metabolism | 7 | 2021 | 222 | 1.090 |
Why?
|
| High-Throughput Screening Assays | 4 | 2015 | 48 | 1.060 |
Why?
|
| Histocompatibility Antigens Class II | 11 | 2007 | 77 | 0.980 |
Why?
|
| Oxygen Consumption | 17 | 2017 | 258 | 0.940 |
Why?
|
| Retinal Cone Photoreceptor Cells | 2 | 2021 | 74 | 0.830 |
Why?
|
| Cell Respiration | 9 | 2021 | 47 | 0.820 |
Why?
|
| Aza Compounds | 2 | 2018 | 7 | 0.810 |
Why?
|
| Myelin Basic Protein | 6 | 2018 | 62 | 0.810 |
Why?
|
| Retinal Pigment Epithelium | 3 | 2021 | 145 | 0.800 |
Why?
|
| T-Lymphocytes | 10 | 2019 | 597 | 0.790 |
Why?
|
| Animals | 68 | 2022 | 20881 | 0.740 |
Why?
|
| Retinal Degeneration | 1 | 2021 | 75 | 0.710 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 3 | 2018 | 133 | 0.670 |
Why?
|
| Disease Models, Animal | 5 | 2021 | 2550 | 0.660 |
Why?
|
| Oxidative Stress | 5 | 2021 | 718 | 0.650 |
Why?
|
| Peptide Fragments | 9 | 2005 | 483 | 0.630 |
Why?
|
| Mice | 40 | 2022 | 8474 | 0.620 |
Why?
|
| Kidney Tubules, Proximal | 7 | 2019 | 81 | 0.610 |
Why?
|
| Stress, Physiological | 3 | 2016 | 215 | 0.590 |
Why?
|
| Mycobacterium tuberculosis | 3 | 2007 | 103 | 0.560 |
Why?
|
| Photoreceptor Cells, Vertebrate | 2 | 2021 | 46 | 0.560 |
Why?
|
| Glycolysis | 9 | 2018 | 79 | 0.550 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2017 | 331 | 0.530 |
Why?
|
| Toxicity Tests | 1 | 2015 | 26 | 0.500 |
Why?
|
| Transcription Factors | 5 | 2016 | 753 | 0.500 |
Why?
|
| Cell Line | 16 | 2021 | 1752 | 0.500 |
Why?
|
| Cells, Cultured | 15 | 2022 | 2673 | 0.450 |
Why?
|
| Fatty Acids | 3 | 2015 | 222 | 0.430 |
Why?
|
| Organelle Biogenesis | 6 | 2018 | 34 | 0.430 |
Why?
|
| Iron | 3 | 2016 | 197 | 0.430 |
Why?
|
| NAD | 3 | 2018 | 73 | 0.430 |
Why?
|
| Receptors, Serotonin | 3 | 2018 | 74 | 0.420 |
Why?
|
| Acute Kidney Injury | 4 | 2018 | 232 | 0.420 |
Why?
|
| Myocytes, Cardiac | 5 | 2017 | 442 | 0.410 |
Why?
|
| Peptides | 8 | 2012 | 455 | 0.410 |
Why?
|
| Heat-Shock Proteins | 1 | 2012 | 69 | 0.400 |
Why?
|
| Calcium | 10 | 2022 | 929 | 0.390 |
Why?
|
| Acetylglucosamine | 1 | 2012 | 46 | 0.390 |
Why?
|
| Membrane Potential, Mitochondrial | 6 | 2019 | 93 | 0.380 |
Why?
|
| Bacterial Proteins | 5 | 2015 | 245 | 0.380 |
Why?
|
| Ovalbumin | 2 | 2001 | 33 | 0.370 |
Why?
|
| Epithelial Cells | 6 | 2021 | 431 | 0.370 |
Why?
|
| Formoterol Fumarate | 4 | 2019 | 25 | 0.370 |
Why?
|
| Repressor Proteins | 3 | 2007 | 183 | 0.360 |
Why?
|
| DNA, Mitochondrial | 5 | 2018 | 84 | 0.350 |
Why?
|
| Calpain | 4 | 2014 | 205 | 0.350 |
Why?
|
| Aging | 1 | 2016 | 911 | 0.340 |
Why?
|
| Rabbits | 9 | 2017 | 509 | 0.340 |
Why?
|
| Iron Chelating Agents | 2 | 2022 | 31 | 0.340 |
Why?
|
| Extracellular Fluid | 1 | 2008 | 29 | 0.310 |
Why?
|
| Reactive Oxygen Species | 6 | 2017 | 499 | 0.310 |
Why?
|
| Oxidative Phosphorylation | 5 | 2019 | 54 | 0.300 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2007 | 16 | 0.300 |
Why?
|
| Antitubercular Agents | 1 | 2007 | 57 | 0.290 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2019 | 304 | 0.290 |
Why?
|
| Receptors, Antigen, T-Cell | 6 | 2017 | 135 | 0.280 |
Why?
|
| Reperfusion Injury | 4 | 2019 | 320 | 0.280 |
Why?
|
| PPAR gamma | 3 | 2019 | 95 | 0.280 |
Why?
|
| Monitoring, Physiologic | 1 | 2008 | 219 | 0.280 |
Why?
|
| Adenosine Triphosphate | 8 | 2021 | 314 | 0.280 |
Why?
|
| Cell Survival | 7 | 2021 | 901 | 0.270 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2019 | 756 | 0.260 |
Why?
|
| Hepatocytes | 3 | 2018 | 205 | 0.260 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2018 | 132 | 0.260 |
Why?
|
| Models, Molecular | 9 | 2017 | 546 | 0.260 |
Why?
|
| Mitochondria, Liver | 2 | 2019 | 148 | 0.240 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2017 | 126 | 0.240 |
Why?
|
| Hyaluronan Receptors | 3 | 2017 | 142 | 0.240 |
Why?
|
| Kidney | 6 | 2018 | 945 | 0.240 |
Why?
|
| Superoxide Dismutase | 2 | 2016 | 149 | 0.240 |
Why?
|
| Lymphocyte Activation | 8 | 2017 | 397 | 0.240 |
Why?
|
| Cell Line, Tumor | 7 | 2019 | 1851 | 0.240 |
Why?
|
| Astrocytes | 3 | 2016 | 270 | 0.240 |
Why?
|
| Signal Transduction | 15 | 2019 | 2689 | 0.240 |
Why?
|
| Biosensing Techniques | 3 | 2013 | 51 | 0.240 |
Why?
|
| Kinetics | 8 | 2007 | 1047 | 0.230 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2016 | 99 | 0.230 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2020 | 137 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 11 | 2019 | 2791 | 0.230 |
Why?
|
| Neoplasms | 4 | 2017 | 1667 | 0.230 |
Why?
|
| Radioisotopes | 1 | 2003 | 40 | 0.220 |
Why?
|
| Molecular Sequence Data | 12 | 2010 | 1447 | 0.220 |
Why?
|
| Immunoconjugates | 1 | 2003 | 26 | 0.220 |
Why?
|
| Proton Pumps | 2 | 2015 | 13 | 0.220 |
Why?
|
| Ethanolamines | 2 | 2014 | 33 | 0.220 |
Why?
|
| Humans | 36 | 2021 | 68618 | 0.220 |
Why?
|
| Glucose | 2 | 2018 | 307 | 0.220 |
Why?
|
| Gastric Mucosa | 2 | 2015 | 77 | 0.210 |
Why?
|
| Antineoplastic Agents | 3 | 2019 | 1070 | 0.210 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2021 | 116 | 0.210 |
Why?
|
| Helicobacter pylori | 2 | 2015 | 54 | 0.210 |
Why?
|
| Retina | 2 | 2016 | 252 | 0.210 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 4 | 2018 | 51 | 0.200 |
Why?
|
| Glutamine | 2 | 2019 | 45 | 0.200 |
Why?
|
| Myocardium | 3 | 2017 | 1204 | 0.200 |
Why?
|
| Amino Acid Sequence | 12 | 2010 | 1083 | 0.200 |
Why?
|
| Environmental Pollutants | 2 | 2013 | 180 | 0.190 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2019 | 331 | 0.190 |
Why?
|
| Fluorescent Dyes | 1 | 2022 | 191 | 0.190 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 3 | 2016 | 14 | 0.190 |
Why?
|
| Protein Binding | 9 | 2012 | 1027 | 0.190 |
Why?
|
| Molecular Biology | 1 | 2021 | 31 | 0.190 |
Why?
|
| Cytological Techniques | 1 | 2021 | 23 | 0.190 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 2019 | 201 | 0.190 |
Why?
|
| Receptors, Complement | 1 | 2021 | 58 | 0.180 |
Why?
|
| Electron Transport | 3 | 2015 | 37 | 0.180 |
Why?
|
| Podocytes | 2 | 2013 | 113 | 0.180 |
Why?
|
| Drug Design | 4 | 2012 | 107 | 0.180 |
Why?
|
| Mitochondrial Diseases | 2 | 2021 | 24 | 0.180 |
Why?
|
| Organoids | 1 | 2020 | 42 | 0.180 |
Why?
|
| Organ Culture Techniques | 2 | 2021 | 122 | 0.180 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 532 | 0.170 |
Why?
|
| Antigen-Presenting Cells | 2 | 1997 | 50 | 0.170 |
Why?
|
| Hydrogen Peroxide | 2 | 2021 | 168 | 0.170 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 3 | 2015 | 13 | 0.170 |
Why?
|
| Cellular Reprogramming | 1 | 2019 | 22 | 0.170 |
Why?
|
| Models, Cardiovascular | 1 | 2020 | 133 | 0.170 |
Why?
|
| Mice, Transgenic | 9 | 2016 | 1033 | 0.170 |
Why?
|
| Simvastatin | 1 | 2019 | 34 | 0.160 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2019 | 34 | 0.160 |
Why?
|
| Proton Ionophores | 2 | 2016 | 7 | 0.160 |
Why?
|
| Oxidants | 2 | 2016 | 48 | 0.160 |
Why?
|
| Thiazolidines | 1 | 2018 | 23 | 0.160 |
Why?
|
| Lovastatin | 1 | 2019 | 78 | 0.160 |
Why?
|
| Melanoma, Experimental | 1 | 2019 | 95 | 0.160 |
Why?
|
| Primary Cell Culture | 2 | 2016 | 56 | 0.160 |
Why?
|
| Oxygen | 4 | 2020 | 386 | 0.160 |
Why?
|
| Protein Structure, Tertiary | 4 | 2012 | 322 | 0.160 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 2015 | 72 | 0.160 |
Why?
|
| Neuroprotective Agents | 1 | 2021 | 317 | 0.150 |
Why?
|
| Neoplasms, Experimental | 1 | 2018 | 118 | 0.150 |
Why?
|
| Cell Death | 3 | 2016 | 329 | 0.150 |
Why?
|
| Esophageal Neoplasms | 1 | 2019 | 150 | 0.150 |
Why?
|
| Lysophospholipids | 1 | 2019 | 209 | 0.150 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2018 | 87 | 0.150 |
Why?
|
| Biphenyl Compounds | 1 | 2018 | 184 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 1 | 2018 | 87 | 0.150 |
Why?
|
| Clenbuterol | 1 | 2017 | 9 | 0.150 |
Why?
|
| Male | 18 | 2019 | 37321 | 0.150 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2017 | 24 | 0.150 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 1998 | 29 | 0.150 |
Why?
|
| Hydrogen Bonding | 5 | 2007 | 67 | 0.150 |
Why?
|
| Sphingosine | 1 | 2019 | 315 | 0.150 |
Why?
|
| Acute Disease | 2 | 2016 | 658 | 0.150 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2018 | 86 | 0.140 |
Why?
|
| Heart | 2 | 2020 | 850 | 0.140 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2017 | 42 | 0.140 |
Why?
|
| Ligands | 6 | 2005 | 317 | 0.140 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 212 | 0.140 |
Why?
|
| Catalase | 2 | 2014 | 85 | 0.140 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2017 | 84 | 0.140 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 163 | 0.140 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 332 | 0.140 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2017 | 99 | 0.140 |
Why?
|
| Homeostasis | 1 | 2018 | 291 | 0.140 |
Why?
|
| Myofibroblasts | 1 | 2017 | 60 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2017 | 147 | 0.140 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 2 | 2014 | 27 | 0.140 |
Why?
|
| Deferoxamine | 1 | 2016 | 45 | 0.140 |
Why?
|
| Serotonin 5-HT2 Receptor Agonists | 1 | 2016 | 1 | 0.140 |
Why?
|
| Serotonin 5-HT2 Receptor Antagonists | 1 | 2016 | 1 | 0.140 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 1 | 2016 | 10 | 0.130 |
Why?
|
| Cysteine Proteinase Inhibitors | 2 | 2014 | 73 | 0.130 |
Why?
|
| Hypoglycemic Agents | 1 | 2019 | 362 | 0.130 |
Why?
|
| Minocycline | 1 | 2016 | 61 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 247 | 0.130 |
Why?
|
| Superoxides | 1 | 2016 | 70 | 0.130 |
Why?
|
| Immunotherapy | 1 | 2017 | 215 | 0.130 |
Why?
|
| Mice, Mutant Strains | 1 | 2016 | 166 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 4 | 2013 | 852 | 0.130 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2014 | 209 | 0.130 |
Why?
|
| Lysosomes | 1 | 2016 | 136 | 0.130 |
Why?
|
| Motor Neurons | 1 | 2016 | 98 | 0.130 |
Why?
|
| Biological Products | 1 | 2016 | 78 | 0.130 |
Why?
|
| Pulmonary Fibrosis | 1 | 2017 | 157 | 0.130 |
Why?
|
| Mutation, Missense | 1 | 2016 | 112 | 0.130 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 334 | 0.120 |
Why?
|
| Myoglobin | 1 | 1994 | 6 | 0.120 |
Why?
|
| Propylamines | 1 | 2014 | 22 | 0.120 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2016 | 131 | 0.120 |
Why?
|
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | 2 | 2014 | 11 | 0.120 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 370 | 0.120 |
Why?
|
| Mice, Knockout | 5 | 2019 | 1692 | 0.120 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 807 | 0.120 |
Why?
|
| Adrenoleukodystrophy | 1 | 2015 | 45 | 0.120 |
Why?
|
| Muscular Atrophy | 1 | 2014 | 35 | 0.120 |
Why?
|
| Blotting, Western | 5 | 2021 | 954 | 0.120 |
Why?
|
| Receptors, Estrogen | 1 | 2015 | 142 | 0.120 |
Why?
|
| Hydroxamic Acids | 1 | 2015 | 84 | 0.120 |
Why?
|
| Helicobacter Infections | 2 | 2015 | 40 | 0.120 |
Why?
|
| Binding Sites | 6 | 2007 | 631 | 0.120 |
Why?
|
| Oxidation-Reduction | 2 | 2016 | 567 | 0.120 |
Why?
|
| Gastric Acid | 2 | 2015 | 71 | 0.120 |
Why?
|
| Glaucoma | 2 | 1992 | 50 | 0.120 |
Why?
|
| Chronic Disease | 2 | 2016 | 1330 | 0.120 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2014 | 34 | 0.120 |
Why?
|
| Sulfhydryl Compounds | 1 | 2014 | 73 | 0.120 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2015 | 120 | 0.120 |
Why?
|
| Gene Deletion | 1 | 2015 | 235 | 0.110 |
Why?
|
| Immunomodulation | 1 | 2014 | 35 | 0.110 |
Why?
|
| Dexamethasone | 1 | 2014 | 150 | 0.110 |
Why?
|
| Carbamates | 1 | 2014 | 41 | 0.110 |
Why?
|
| Dimerization | 4 | 2012 | 99 | 0.110 |
Why?
|
| Multiple Sclerosis | 2 | 2014 | 132 | 0.110 |
Why?
|
| Female | 16 | 2019 | 38074 | 0.110 |
Why?
|
| Rats | 7 | 2018 | 5300 | 0.110 |
Why?
|
| Nerve Degeneration | 1 | 2014 | 134 | 0.110 |
Why?
|
| Mitochondrial Membranes | 1 | 2013 | 45 | 0.110 |
Why?
|
| NF-kappa B | 1 | 2015 | 432 | 0.110 |
Why?
|
| Up-Regulation | 2 | 2014 | 682 | 0.110 |
Why?
|
| Artificial Intelligence | 1 | 2014 | 159 | 0.110 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2004 | 112 | 0.110 |
Why?
|
| Hyaluronic Acid | 2 | 2017 | 206 | 0.110 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 333 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2013 | 118 | 0.110 |
Why?
|
| Base Sequence | 3 | 2018 | 1015 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2013 | 1745 | 0.100 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2014 | 266 | 0.100 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2012 | 5 | 0.100 |
Why?
|
| Lung | 1 | 2017 | 849 | 0.100 |
Why?
|
| Epoxy Compounds | 1 | 2012 | 20 | 0.100 |
Why?
|
| Mitochondria, Heart | 1 | 2012 | 53 | 0.100 |
Why?
|
| Acetaldehyde | 1 | 2012 | 18 | 0.100 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2012 | 92 | 0.100 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2011 | 108 | 0.100 |
Why?
|
| Thiazolidinediones | 1 | 2012 | 77 | 0.100 |
Why?
|
| Nanofibers | 1 | 2012 | 21 | 0.100 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2012 | 45 | 0.100 |
Why?
|
| Urea | 1 | 2012 | 51 | 0.100 |
Why?
|
| Cell Membrane | 2 | 2014 | 525 | 0.100 |
Why?
|
| Mutation | 4 | 2018 | 1213 | 0.100 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2012 | 153 | 0.100 |
Why?
|
| Immune Tolerance | 3 | 2003 | 114 | 0.100 |
Why?
|
| DNA Damage | 1 | 2013 | 190 | 0.100 |
Why?
|
| Sclerostomy | 1 | 1991 | 3 | 0.100 |
Why?
|
| Embryo, Nonmammalian | 1 | 2011 | 64 | 0.100 |
Why?
|
| Microarray Analysis | 1 | 2011 | 63 | 0.100 |
Why?
|
| Virulence | 2 | 2010 | 51 | 0.100 |
Why?
|
| Protein Kinases | 1 | 2012 | 122 | 0.100 |
Why?
|
| Cell Differentiation | 2 | 2018 | 1034 | 0.100 |
Why?
|
| Molecular Structure | 4 | 2016 | 397 | 0.100 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2017 | 226 | 0.100 |
Why?
|
| Laser Therapy | 1 | 1991 | 54 | 0.090 |
Why?
|
| Hep G2 Cells | 3 | 2019 | 68 | 0.090 |
Why?
|
| Zebrafish | 1 | 2011 | 187 | 0.090 |
Why?
|
| Mercuric Chloride | 1 | 2010 | 3 | 0.090 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2010 | 7 | 0.090 |
Why?
|
| Amphetamines | 1 | 2010 | 10 | 0.090 |
Why?
|
| H(+)-K(+)-Exchanging ATPase | 1 | 2010 | 45 | 0.090 |
Why?
|
| Smegmamorpha | 1 | 2010 | 7 | 0.090 |
Why?
|
| Procollagen-Proline Dioxygenase | 2 | 2008 | 17 | 0.090 |
Why?
|
| Biomarkers | 2 | 2015 | 1593 | 0.090 |
Why?
|
| Central Nervous System Depressants | 1 | 2012 | 182 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 1173 | 0.090 |
Why?
|
| Gentamicins | 1 | 2010 | 68 | 0.090 |
Why?
|
| Cell Culture Techniques | 3 | 2021 | 189 | 0.090 |
Why?
|
| Protein Conformation | 3 | 2012 | 362 | 0.090 |
Why?
|
| Apoptosis | 3 | 2013 | 1641 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 219 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 1 | 2011 | 183 | 0.090 |
Why?
|
| HLA-D Antigens | 2 | 2007 | 20 | 0.090 |
Why?
|
| Receptors, IgG | 1 | 2010 | 94 | 0.080 |
Why?
|
| Ovarian Neoplasms | 1 | 2011 | 267 | 0.080 |
Why?
|
| Cisplatin | 1 | 2010 | 192 | 0.080 |
Why?
|
| Osteoclasts | 1 | 2010 | 132 | 0.080 |
Why?
|
| Peroxiredoxins | 1 | 2009 | 34 | 0.080 |
Why?
|
| Treatment Outcome | 2 | 2018 | 7029 | 0.080 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2009 | 15 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 1 | 2012 | 332 | 0.080 |
Why?
|
| Lactates | 1 | 2009 | 29 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 214 | 0.080 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2009 | 48 | 0.080 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 1999 | 38 | 0.080 |
Why?
|
| Basigin | 1 | 2009 | 53 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2017 | 216 | 0.080 |
Why?
|
| Ceramides | 1 | 2012 | 578 | 0.080 |
Why?
|
| Cats | 3 | 2015 | 292 | 0.080 |
Why?
|
| Anti-Infective Agents | 1 | 2010 | 166 | 0.080 |
Why?
|
| Phosphorylation | 3 | 2017 | 1200 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2013 | 618 | 0.080 |
Why?
|
| Fumarates | 1 | 2008 | 28 | 0.080 |
Why?
|
| Mice, SCID | 2 | 2011 | 238 | 0.080 |
Why?
|
| Antigens, CD | 1 | 2009 | 230 | 0.080 |
Why?
|
| Metals | 2 | 2007 | 100 | 0.070 |
Why?
|
| Muscle, Skeletal | 2 | 2014 | 396 | 0.070 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2007 | 47 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2012 | 381 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 507 | 0.070 |
Why?
|
| Fluorobenzenes | 2 | 2017 | 10 | 0.070 |
Why?
|
| Lactic Acid | 2 | 2008 | 86 | 0.070 |
Why?
|
| Cytosol | 2 | 2019 | 123 | 0.070 |
Why?
|
| Carbazoles | 2 | 2017 | 46 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 659 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2007 | 236 | 0.060 |
Why?
|
| Antigen Presentation | 2 | 2003 | 76 | 0.060 |
Why?
|
| Alanine | 1 | 2005 | 38 | 0.060 |
Why?
|
| Ethanol | 1 | 2012 | 893 | 0.060 |
Why?
|
| Superoxide Dismutase-1 | 2 | 2016 | 41 | 0.060 |
Why?
|
| src Homology Domains | 1 | 2004 | 29 | 0.060 |
Why?
|
| Nickel | 1 | 2004 | 18 | 0.060 |
Why?
|
| Mutagenesis | 1 | 2004 | 60 | 0.060 |
Why?
|
| Ions | 1 | 2004 | 50 | 0.060 |
Why?
|
| Lipoproteins, HDL | 1 | 2005 | 113 | 0.060 |
Why?
|
| Tryptophan | 1 | 2004 | 65 | 0.060 |
Why?
|
| Anisotropy | 1 | 2004 | 105 | 0.060 |
Why?
|
| Indoles | 2 | 2016 | 146 | 0.060 |
Why?
|
| Pyrococcus furiosus | 1 | 2003 | 5 | 0.060 |
Why?
|
| Glucose-6-Phosphate Isomerase | 1 | 2003 | 10 | 0.060 |
Why?
|
| Plasmids | 1 | 2004 | 258 | 0.060 |
Why?
|
| Aged | 3 | 2016 | 14862 | 0.060 |
Why?
|
| Fluorine Radioisotopes | 1 | 2003 | 13 | 0.060 |
Why?
|
| Mice, Inbred NOD | 1 | 2003 | 138 | 0.050 |
Why?
|
| Molecular Probes | 1 | 2003 | 27 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2003 | 282 | 0.050 |
Why?
|
| Antigens, Bacterial | 2 | 2015 | 54 | 0.050 |
Why?
|
| Amino Acid Substitution | 3 | 2016 | 137 | 0.050 |
Why?
|
| Oxyquinoline | 1 | 2022 | 6 | 0.050 |
Why?
|
| Cytochrome c Group | 3 | 1997 | 22 | 0.050 |
Why?
|
| Rhodamine 123 | 1 | 2022 | 13 | 0.050 |
Why?
|
| Thapsigargin | 1 | 2022 | 18 | 0.050 |
Why?
|
| Cations, Divalent | 1 | 2022 | 27 | 0.050 |
Why?
|
| Molecular Probe Techniques | 1 | 2002 | 7 | 0.050 |
Why?
|
| Structure-Activity Relationship | 2 | 2013 | 420 | 0.050 |
Why?
|
| Tyrosine | 1 | 2003 | 196 | 0.050 |
Why?
|
| Autoimmunity | 1 | 2003 | 118 | 0.050 |
Why?
|
| Fluorescence | 1 | 2022 | 104 | 0.050 |
Why?
|
| Lymphoma, B-Cell | 1 | 2002 | 40 | 0.050 |
Why?
|
| Radiometry | 1 | 2002 | 64 | 0.050 |
Why?
|
| DNA | 1 | 2004 | 597 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2022 | 113 | 0.050 |
Why?
|
| Electron Transport Complex IV | 2 | 2014 | 33 | 0.050 |
Why?
|
| Calcium Signaling | 2 | 2019 | 97 | 0.050 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2021 | 19 | 0.050 |
Why?
|
| Major Histocompatibility Complex | 2 | 1998 | 34 | 0.050 |
Why?
|
| Calcium Chelating Agents | 1 | 2021 | 5 | 0.050 |
Why?
|
| Interleukin-2 | 1 | 2001 | 133 | 0.050 |
Why?
|
| Phenotype | 2 | 2014 | 947 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2015 | 615 | 0.050 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2012 | 73 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 1293 | 0.050 |
Why?
|
| Endocytosis | 1 | 2021 | 113 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 700 | 0.050 |
Why?
|
| Myocardial Contraction | 2 | 2015 | 383 | 0.050 |
Why?
|
| Cardiotoxicity | 1 | 2020 | 12 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2017 | 2083 | 0.040 |
Why?
|
| Protein Transport | 1 | 2021 | 280 | 0.040 |
Why?
|
| Immunodominant Epitopes | 1 | 1999 | 13 | 0.040 |
Why?
|
| Binding, Competitive | 2 | 2003 | 165 | 0.040 |
Why?
|
| Lysine | 1 | 2000 | 96 | 0.040 |
Why?
|
| Arginine | 1 | 2000 | 102 | 0.040 |
Why?
|
| Phenformin | 1 | 2019 | 3 | 0.040 |
Why?
|
| Glutaminase | 1 | 2019 | 7 | 0.040 |
Why?
|
| Thiadiazoles | 1 | 2019 | 7 | 0.040 |
Why?
|
| Benzeneacetamides | 1 | 2019 | 11 | 0.040 |
Why?
|
| F-Box Proteins | 1 | 2019 | 14 | 0.040 |
Why?
|
| Proteins | 1 | 2003 | 474 | 0.040 |
Why?
|
| Cyclin D1 | 1 | 2019 | 37 | 0.040 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2019 | 63 | 0.040 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2019 | 32 | 0.040 |
Why?
|
| Fibroblasts | 2 | 2017 | 902 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2019 | 28 | 0.040 |
Why?
|
| Ribonucleotide Reductases | 1 | 2018 | 9 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2019 | 36 | 0.040 |
Why?
|
| Histocompatibility Antigens | 1 | 1998 | 12 | 0.040 |
Why?
|
| Retinoblastoma Protein | 1 | 2019 | 75 | 0.040 |
Why?
|
| Microscopy, Confocal | 2 | 2010 | 337 | 0.040 |
Why?
|
| Metformin | 1 | 2019 | 63 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1999 | 126 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 2013 | 742 | 0.040 |
Why?
|
| Cyclic AMP | 1 | 2019 | 223 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2019 | 260 | 0.040 |
Why?
|
| Kidney Cortex | 1 | 2018 | 19 | 0.040 |
Why?
|
| Epitope Mapping | 1 | 1998 | 10 | 0.040 |
Why?
|
| Syndrome | 1 | 2018 | 255 | 0.040 |
Why?
|
| Succinate Dehydrogenase | 1 | 2017 | 13 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 170 | 0.040 |
Why?
|
| Serotonin 5-HT1 Receptor Agonists | 1 | 2017 | 3 | 0.040 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2017 | 20 | 0.040 |
Why?
|
| Histone Deacetylase 1 | 1 | 2017 | 32 | 0.040 |
Why?
|
| Amino Acids, Dicarboxylic | 2 | 2008 | 3 | 0.040 |
Why?
|
| Second Messenger Systems | 1 | 2017 | 53 | 0.040 |
Why?
|
| Antibodies | 1 | 2018 | 241 | 0.040 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2017 | 13 | 0.040 |
Why?
|
| Ventricular Function | 1 | 2017 | 93 | 0.040 |
Why?
|
| Sirtuin 1 | 1 | 2017 | 47 | 0.040 |
Why?
|
| L-Selectin | 1 | 2017 | 28 | 0.040 |
Why?
|
| Spectrum Analysis | 2 | 2012 | 81 | 0.040 |
Why?
|
| Cyclic GMP | 1 | 2017 | 99 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2017 | 128 | 0.040 |
Why?
|
| Hyaluronan Synthases | 1 | 2017 | 21 | 0.040 |
Why?
|
| Glucuronosyltransferase | 1 | 2017 | 38 | 0.040 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2008 | 71 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 689 | 0.040 |
Why?
|
| Th1 Cells | 1 | 2017 | 101 | 0.040 |
Why?
|
| Substrate Specificity | 2 | 2010 | 234 | 0.040 |
Why?
|
| Disease | 1 | 2016 | 41 | 0.030 |
Why?
|
| Time Factors | 2 | 2013 | 4655 | 0.030 |
Why?
|
| Th17 Cells | 1 | 2017 | 116 | 0.030 |
Why?
|
| Ruthenium Compounds | 1 | 2016 | 5 | 0.030 |
Why?
|
| Starch | 1 | 2016 | 18 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2017 | 223 | 0.030 |
Why?
|
| Animals, Newborn | 2 | 2008 | 396 | 0.030 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 1 | 2016 | 2 | 0.030 |
Why?
|
| Electron Transport Complex I | 1 | 2016 | 20 | 0.030 |
Why?
|
| Aminopyridines | 1 | 2016 | 26 | 0.030 |
Why?
|
| Pyrazines | 1 | 2016 | 46 | 0.030 |
Why?
|
| Achlorhydria | 1 | 2015 | 5 | 0.030 |
Why?
|
| Virulence Factors | 1 | 2015 | 11 | 0.030 |
Why?
|
| Acetaminophen | 1 | 2016 | 111 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2019 | 506 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2015 | 71 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 196 | 0.030 |
Why?
|
| tert-Butylhydroperoxide | 1 | 2014 | 14 | 0.030 |
Why?
|
| Atomoxetine Hydrochloride | 1 | 2014 | 14 | 0.030 |
Why?
|
| Crystallography, X-Ray | 2 | 2007 | 190 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2017 | 384 | 0.030 |
Why?
|
| Muramidase | 1 | 1994 | 38 | 0.030 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2014 | 35 | 0.030 |
Why?
|
| Piperazines | 1 | 2016 | 206 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2015 | 218 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2015 | 246 | 0.030 |
Why?
|
| Oligodendroglia | 1 | 2015 | 107 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 2014 | 75 | 0.030 |
Why?
|
| Hypoxia | 1 | 2015 | 169 | 0.030 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2014 | 41 | 0.030 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2013 | 15 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2014 | 160 | 0.030 |
Why?
|
| Macromolecular Substances | 2 | 2007 | 122 | 0.030 |
Why?
|
| Cell Separation | 1 | 2014 | 132 | 0.030 |
Why?
|
| Aniline Compounds | 1 | 2013 | 52 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 1994 | 765 | 0.030 |
Why?
|
| Benzamides | 1 | 2014 | 156 | 0.030 |
Why?
|
| Monocytes | 1 | 2014 | 210 | 0.030 |
Why?
|
| Carbocyanines | 1 | 2012 | 13 | 0.030 |
Why?
|
| Cardiolipins | 1 | 2012 | 12 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2014 | 489 | 0.030 |
Why?
|
| Cytochromes c | 1 | 2012 | 75 | 0.030 |
Why?
|
| Biochemistry | 1 | 2012 | 12 | 0.030 |
Why?
|
| Coloring Agents | 1 | 2012 | 66 | 0.030 |
Why?
|
| Oleic Acid | 1 | 2012 | 40 | 0.030 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2012 | 77 | 0.030 |
Why?
|
| Deoxycytidine | 1 | 2012 | 83 | 0.030 |
Why?
|
| Mitomycins | 1 | 1992 | 4 | 0.030 |
Why?
|
| Trabeculectomy | 1 | 1992 | 5 | 0.030 |
Why?
|
| Fluoxetine | 1 | 2012 | 40 | 0.030 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2012 | 11 | 0.030 |
Why?
|
| Isoproterenol | 1 | 2012 | 163 | 0.030 |
Why?
|
| Enzyme Activators | 1 | 2012 | 14 | 0.030 |
Why?
|
| Cysteine | 1 | 2012 | 112 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2012 | 294 | 0.030 |
Why?
|
| Propanolamines | 1 | 2012 | 70 | 0.020 |
Why?
|
| Voltage-Dependent Anion Channels | 1 | 2012 | 40 | 0.020 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2012 | 32 | 0.020 |
Why?
|
| Fluorouracil | 1 | 1992 | 130 | 0.020 |
Why?
|
| Benzimidazoles | 1 | 2012 | 128 | 0.020 |
Why?
|
| Protons | 1 | 2011 | 57 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2011 | 121 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1174 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2012 | 189 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2011 | 132 | 0.020 |
Why?
|
| Syk Kinase | 1 | 2010 | 10 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2011 | 137 | 0.020 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2010 | 14 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2011 | 132 | 0.020 |
Why?
|
| LIM Domain Proteins | 1 | 2010 | 15 | 0.020 |
Why?
|
| Genes, Bacterial | 1 | 2010 | 40 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2010 | 62 | 0.020 |
Why?
|
| Disease Progression | 1 | 2014 | 1038 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2010 | 69 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 100 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2011 | 148 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 1864 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2012 | 306 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2010 | 181 | 0.020 |
Why?
|
| Linear Models | 1 | 2011 | 521 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2010 | 195 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1174 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 1465 | 0.020 |
Why?
|
| RNA Interference | 1 | 2010 | 266 | 0.020 |
Why?
|
| Fura-2 | 1 | 2009 | 21 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2013 | 617 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2009 | 59 | 0.020 |
Why?
|
| Hybridomas | 2 | 1999 | 25 | 0.020 |
Why?
|
| Kidney Glomerulus | 1 | 2010 | 155 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 710 | 0.020 |
Why?
|
| Neurons | 1 | 2014 | 881 | 0.020 |
Why?
|
| Biological Transport | 1 | 2009 | 210 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1999 | 204 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2009 | 101 | 0.020 |
Why?
|
| Dipeptides | 1 | 2009 | 89 | 0.020 |
Why?
|
| 2,4-Dinitrophenol | 1 | 2008 | 6 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 782 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2009 | 238 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2011 | 508 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2007 | 31 | 0.020 |
Why?
|
| Moths | 2 | 1997 | 14 | 0.020 |
Why?
|
| Hydroxybenzoates | 1 | 2006 | 9 | 0.020 |
Why?
|
| Cyanides | 1 | 2006 | 15 | 0.020 |
Why?
|
| Deoxyglucose | 1 | 2006 | 32 | 0.020 |
Why?
|
| Glycogen | 1 | 2006 | 27 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2007 | 92 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2006 | 39 | 0.020 |
Why?
|
| Fallopian Tubes | 1 | 1986 | 11 | 0.020 |
Why?
|
| Infertility, Female | 1 | 1986 | 25 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2009 | 307 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2007 | 150 | 0.020 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 1986 | 39 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2010 | 1664 | 0.020 |
Why?
|
| Microsurgery | 1 | 1986 | 46 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 2077 | 0.020 |
Why?
|
| Fertilization in Vitro | 1 | 1986 | 47 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2009 | 475 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2005 | 50 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2005 | 284 | 0.010 |
Why?
|
| Pentosephosphates | 1 | 2003 | 3 | 0.010 |
Why?
|
| Gluconates | 1 | 2003 | 5 | 0.010 |
Why?
|
| Hydrogen | 1 | 2003 | 35 | 0.010 |
Why?
|
| Catalysis | 1 | 2003 | 123 | 0.010 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2003 | 1 | 0.010 |
Why?
|
| Cresols | 1 | 2003 | 17 | 0.010 |
Why?
|
| Scattering, Radiation | 1 | 2003 | 30 | 0.010 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2003 | 38 | 0.010 |
Why?
|
| Solubility | 1 | 2003 | 134 | 0.010 |
Why?
|
| Epitopes | 1 | 2003 | 146 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2003 | 130 | 0.010 |
Why?
|
| Solvents | 1 | 2003 | 109 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1999 | 49 | 0.010 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 1999 | 6 | 0.010 |
Why?
|
| Mice, Neurologic Mutants | 1 | 1999 | 23 | 0.010 |
Why?
|
| CHO Cells | 1 | 1999 | 161 | 0.010 |
Why?
|
| Luminescent Measurements | 1 | 1999 | 58 | 0.010 |
Why?
|
| Cricetinae | 1 | 1999 | 262 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1999 | 136 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2009 | 1536 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 5717 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1999 | 324 | 0.010 |
Why?
|
| Oligopeptides | 1 | 1999 | 152 | 0.010 |
Why?
|
| H-2 Antigens | 1 | 1998 | 7 | 0.010 |
Why?
|
| Immunoglobulin Variable Region | 1 | 1998 | 40 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1998 | 134 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 1998 | 208 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 1998 | 186 | 0.010 |
Why?
|
| CD4 Antigens | 1 | 1996 | 42 | 0.010 |
Why?
|
| Hemoglobins | 1 | 1996 | 120 | 0.010 |
Why?
|
| Middle Aged | 2 | 2010 | 21147 | 0.010 |
Why?
|
| Adult | 2 | 2010 | 21403 | 0.010 |
Why?
|
| Models, Biological | 1 | 1999 | 981 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1996 | 511 | 0.010 |
Why?
|
| Corneal Diseases | 1 | 1992 | 12 | 0.010 |
Why?
|
| Epithelium | 1 | 1992 | 172 | 0.010 |
Why?
|
| Injections | 1 | 1992 | 119 | 0.010 |
Why?
|
| Intraoperative Care | 1 | 1992 | 91 | 0.010 |
Why?
|
| Intraocular Pressure | 1 | 1992 | 143 | 0.010 |
Why?
|
| Postoperative Care | 1 | 1992 | 163 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1992 | 1342 | 0.000 |
Why?
|
| Embryo Transfer | 1 | 1986 | 18 | 0.000 |
Why?
|
| Tissue Adhesions | 1 | 1986 | 21 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1992 | 3705 | 0.000 |
Why?
|
| Laparoscopy | 1 | 1986 | 237 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1992 | 4848 | 0.000 |
Why?
|
| Pregnancy | 1 | 1986 | 2334 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1986 | 3259 | 0.000 |
Why?
|